DENTSPLY SIRONA (NASDAQ:XRAY) Price Target Cut to $30.00 by Analysts at The Goldman Sachs Group

DENTSPLY SIRONA (NASDAQ:XRAY) had its price objective reduced by The Goldman Sachs Group from $34.00 to $30.00 in a research report sent to investors on Monday, Benzinga reports. They currently have a neutral rating on the medical instruments supplier’s stock.

Other equities analysts also recently issued reports about the stock. Robert W. Baird cut their price target on shares of DENTSPLY SIRONA from $35.00 to $33.00 and set a neutral rating for the company in a report on Friday. Leerink Partnrs reissued an outperform rating on shares of DENTSPLY SIRONA in a report on Monday, February 26th. Piper Sandler restated a neutral rating and set a $32.00 price target (down from $35.00) on shares of DENTSPLY SIRONA in a research report on Friday. Needham & Company LLC cut their price objective on DENTSPLY SIRONA from $42.00 to $36.00 and set a buy rating for the company in a research report on Friday. Finally, SVB Leerink began coverage on DENTSPLY SIRONA in a report on Monday, February 26th. They set an outperform rating and a $42.00 target price on the stock. Five research analysts have rated the stock with a hold rating and seven have assigned a buy rating to the stock. Based on data from MarketBeat.com, DENTSPLY SIRONA has a consensus rating of Moderate Buy and a consensus price target of $35.22.

DENTSPLY SIRONA Stock Down 0.1 %

Shares of XRAY opened at $28.25 on Monday. DENTSPLY SIRONA has a 12 month low of $26.27 and a 12 month high of $41.65. The stock has a market cap of $5.87 billion, a price-to-earnings ratio of -64.20, a P/E/G ratio of 1.24 and a beta of 1.00. The company has a 50-day moving average price of $32.02 and a two-hundred day moving average price of $32.69. The company has a quick ratio of 0.97, a current ratio of 1.43 and a debt-to-equity ratio of 0.54.

DENTSPLY SIRONA (NASDAQ:XRAY) last announced its quarterly earnings results on Thursday, May 2nd. The medical instruments supplier reported $0.42 EPS for the quarter, meeting the consensus estimate of $0.42. DENTSPLY SIRONA had a positive return on equity of 11.54% and a negative net margin of 2.41%. The business had revenue of $953.00 million for the quarter, compared to analyst estimates of $969.45 million. During the same quarter in the previous year, the firm earned $0.39 EPS. DENTSPLY SIRONA’s quarterly revenue was down 2.6% on a year-over-year basis. Equities analysts predict that DENTSPLY SIRONA will post 2.04 EPS for the current fiscal year.

DENTSPLY SIRONA Increases Dividend

The company also recently disclosed a quarterly dividend, which was paid on Friday, April 12th. Investors of record on Friday, March 29th were given a $0.16 dividend. This represents a $0.64 dividend on an annualized basis and a yield of 2.27%. This is a positive change from DENTSPLY SIRONA’s previous quarterly dividend of $0.14. The ex-dividend date was Wednesday, March 27th. DENTSPLY SIRONA’s dividend payout ratio (DPR) is presently -145.45%.

Institutional Trading of DENTSPLY SIRONA

Institutional investors have recently bought and sold shares of the business. VisionPoint Advisory Group LLC boosted its holdings in DENTSPLY SIRONA by 104.2% during the third quarter. VisionPoint Advisory Group LLC now owns 774 shares of the medical instruments supplier’s stock worth $26,000 after buying an additional 395 shares during the last quarter. Principal Securities Inc. acquired a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $26,000. Headlands Technologies LLC acquired a new position in DENTSPLY SIRONA during the fourth quarter valued at approximately $30,000. Parkside Financial Bank & Trust increased its stake in DENTSPLY SIRONA by 33.3% in the fourth quarter. Parkside Financial Bank & Trust now owns 1,169 shares of the medical instruments supplier’s stock valued at $42,000 after purchasing an additional 292 shares in the last quarter. Finally, Anchor Investment Management LLC acquired a new stake in DENTSPLY SIRONA in the fourth quarter worth $47,000. Institutional investors and hedge funds own 95.70% of the company’s stock.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.